E

Every

Produces egg proteins via precision fermentation

Overview

EVERY produces egg proteins using precision fermentation, growing microorganisms to make ovalbumin (OvoPro) and other egg proteins as shelf-stable powders for food manufacturers, bakeries, and foodservice. The proteins are designed to be identical to chicken egg proteins but are produced without hens, allowing them to replace eggs or egg whites in many applications and remove cold-chain logistics. It differentiates itself by offering an animal-free, cage-free protein with regulatory clearance, scalable production, and partnerships for distribution, reducing avian disease risk and price swings associated with hen flocks. Its goal is to scale production of reliable, animal-free egg protein at commercial volumes, including exploring dedicated US manufacturing capacity with support from the Department of Defense’s bioindustrial program.

Work here?Claim your company

About Every

Simplify's Rating
Why Every is rated
B
Rated B on Competitive Edge
Rated A on Growth Potential
Rated C on Differentiation

Industries

Food & AgricultureIndustrial & ManufacturingBiotechnology

Company Size

51-200

Company Stage

Series D

Total Funding

$300.8M

Headquarters

Daly City, CA

Founded

2014

Get referred to Every

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • First four months of 2026 brought annual orders equal to 550% of 2025 volume.
  • Mario Patiño joined April 23, 2026 to accelerate U.S., Latin America, EMEA, and APAC sales.
  • Healthier Comforts launched the first consumer animal-free egg white powder on Amazon and direct-to-consumer.

What critics are saying

  • EU expansion still needs regulatory approval, delaying Palacios and overseas revenue until 2027.
  • Onego Bio's patent suit dismissal left EVERY's patent validity and infringement claims unresolved.
  • Customer concentration and fermentation scale-up failures could halt orders and crush the company.

What makes Every unique

  • OvoPro reached Walmart and Target nationwide by April 2026, proving retail demand.
  • Huvepharma's June 2026 deal quadruples production using 9,000,000L Bulgarian fermentation capacity.
  • EVERY owns fermentation-based ovalbumin IP, enabling functional egg replacement across bakery and beverage uses.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$300.8M

Above

Industry Average

Funded Over

9 Rounds

Series D funding is typically for companies that are already well-established but need more funding to continue their growth. This round is often used to stabilize the company or prepare for an IPO.
Series D Funding Comparison
Below Average

Industry standards

$77M
$55M
$70M
$80M
$100M

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Unlimited Paid Time Off
  • Paid Holidays
  • Commuter Benefits
  • Wellness Program
  • Gym Membership
  • 401(k) Company Match
  • Stock Options

Growth & Insights and Company News

6 month growth

1%

1 year growth

1%

2 year growth

-29%
Business Wire
Apr 23rd, 2026
EVERY names Mario Patiño as first CRO following Walmart rollout of precision-fermented proteins

The EVERY Company has appointed Mario Patiño as its first Chief Revenue Officer following its nationwide expansion into Walmart and Target stores. The San Francisco-based precision-fermentation startup produces animal-free protein ingredients for the food industry. Patiño joins from Insight M, where he served as CRO and built international business strategy. He has previously closed over $250 million in customer contracts and built multi-billion dollar pipelines whilst commercialising novel technologies at scale. As CRO, Patiño will drive US mass market adoption, lead global expansion into Latin America, EMEA and Asia-Pacific, and scale commercial infrastructure to meet demand for EVERY's flagship OvoPro product. The appointment follows the company's recent Series D funding round and marks an inflection point as EVERY transitions from concept validation to global scale.

Yahoo Finance
Mar 11th, 2026
Healthier Comforts launches first consumer animal-free egg white protein powder using EVERY's OvoPro™

The EVERY Company is supplying its precision-fermented egg white protein, OvoPro™, to Healthier Comforts for the first time, making the ingredient available to consumers. Healthier Comforts' Animal-Free Egg White Protein Powder launches on its website and Amazon in an 8oz resealable bag designed for home cooking and baking. Previously available only to food manufacturers in bulk, OvoPro™ addresses a gap in the vegan market for functional egg white replacements suitable for meringues, macarons and angel food cake. The product soft-launched in December 2025 and sold out quickly after gaining attention in vegan communities on Reddit. The partnership began when Healthier Comforts founder Aaron Vander Heyden met EVERY at IFT First in Chicago, recognising the potential to serve home cooks with a retail-ready format.

Business Wire
Nov 21st, 2025
EVERY Raises $55 Million in Fresh Capital Ahead of Nationwide Rollout

The EVERY Company, a biotechnology leader pioneering precision fermentation for highly functional proteins, today announced that it has successfully closed o...

IT桔子
Nov 20th, 2025
The Every Company raises $55M Series D

The Every Company has raised $55 million in a Series D funding round.

Food Business Africa
Dec 3rd, 2024
The EVERY Company secures US$2M from US government for protein manufacturing study | Food Business Africa - Africa's No.1 Food & Beverage Manufacturing Industry Magazine and Website

USA - The EVERY Company, a biotechnology firm specializing in animal-free proteins, has received US$2 million in funding from the United States Department o ...

Recently Posted Jobs

Sign up to get curated job recommendations

Every is Hiring for 4 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs